Panther Fusion® GBS Assay
Panther Fusion GBS Assay delivers accurate, automated Group B Streptococcus tesing, helping laboratories streamline workflows and support timely, confident care decisions.1
Accelerate GBS Screening
The Panther Fusion GBS assay brings trusted molecular performance to GBS screening, helping laboratories streamline workflow and expand their Panther Fusion testing menu. Designed to deliver results sooner than traditional culture methods, the assay supports improved sensitivity and greater confidence in results.1,2
Deliver Timely, Reliable Results with Confidence
The Panther Fusion GBS Assay helps laboratories confidentily identify more GBS-positive samples than culture. By reducing missed positives and improving workflow the assay helps strengthen care for both mothers and their newborns.2
Accurate Diagnosis
The Panther Fusion GBS assay delivers up to 100% sensitivity and 96.5% specificity, helping to identify more GBS-positive samples than culture through accurate, automated molecular testing.1
Simplified Testing Pathway
Streamline GBS testing with a streamlined workflow designed to reduce hands-on time, minimise steps and support confident, efficient results — helping labs improve productivity, consistency and turnaround while staying focused on patient care.
Consolidated Molecular Testing
Combine GBS testing with the broad menu on the Panther Fusion® instrument to streamline workflows, reduce complexity and maximise efficiency.
Simplify & Scale the Future of Diagnostics
The Panther Fusion GBS Assay is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high-performing assay menu with high-throughput automation. Designed to flexibly scale to meet your needs, from a single patient result to population-level screening.
Improved Detection for Prenatal GBS Screening
Compared with standard culture, NAAT-based testing may improve the sensitivity of prenatal GBS screening while reducing the time to results. In a recent study, the Panther Fusion GBS assay demonstrated higher sensitivity than culture (95.9% vs 73.5%), detecting more GBS-positive specimens.2 Designed for use on the Panther Fusion System, it also delivers workflow efficiencies through reduced hands-on time and scalable testing capacity.1
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
Insights
- Panther Fusion GBS Assay [Package Insert] AW-23714-001, Rev001, San Diego, Ca, Hologic Inc. 2022.
- Shin JH and Pride DT. Comparison of Three Nucleic Acid Amplification Tests (NAATs) and Culture for Detection of Group B Streptococcus (GBS) from Enrichment Broth. J Clin Microbiology. 2019;57(6):e01958-18.
Documents
Safety Data Sheets
Package Inserts
2797
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
Notified Body number wherever applicable